RADIFY^® for Mammograms

Breast cancer is the most common cancer affecting women worldwide.
More than 200 million women are examined each year around the globe.

AI can assist Radiologists improve the accuracy and reading of screening Mammography.

Mammography has been the frontline screening tool for breast cancer for decades. We’ve developed RADIFY^® for mammograms as a clinical decision support tool for radiologists when screening for breast cancer.

Mammography relies on a specialist radiologist for interpretation.

RADIFY^® use Case 1

Screening mammogram of a 53 year old female.

Left MLO view demonstrating two benign lesions detected by RADIFY® in the left mid and outer regions. Ultrasound confirmed benign mass and classified as BIRADS 3.

RADIFY^® use Case 2

Screening mammogram of a 47 year old female.

Left breast MLO view demonstrating two lesions detected by RADIFY®. One benign lesion and a second mass with malignant features confirmed on ultrasound and biopsy.

Additional Tele-radiology support is provided by our team of radiologists through our RADIFY^® Platform. Contact us for more details by completing the form below.

How we can help Radiologists:

With the concurrent use of RADIFY® for mammography, we can improve the accuracy and effectiveness of detecting breast cancer.

Highlights regions of interest which can be compared on follow–up studies
Use to prioritise scans during case overload
Reducing turn-around -time will increase the number of patients served
Use as a triage system to identify patients most need of urgent care

Let’s Connect

RADIFY® for Mammograms

Breast cancer is the most common cancer affecting women worldwide.More than 200 million women are examined each year around the globe.

RADIFY^® for Mammograms

Breast cancer is the most common cancer affecting women worldwide.
More than 200 million women are examined each year around the globe.